Date | Name | Activity | Value |
---|---|---|---|
Dec 11, 2023 | Lee Flowers Svp Of Business Development | Bought | $1050 |
Dec 11, 2023 | Peter Rhode Chief Scientific Officer And Vp Of Clinical Operations | Bought | $1960 |
Nov 20, 2023 | Peter Rhode Chief Scientific Officer And Vp Of Clinical Operations | Bought | $2100 |
Oct 23, 2023 | Rebecca Byam Cfo | Bought | $6615 |
Holder | # of Shares | Type | % Holding | Value |
---|---|---|---|---|
205,142 | Institution | 0.54% | 286,994 | |
127,757 | Institution | 0.34% | 178,732 | |
84,700 | Institution | 0.22% | 118,495 | |
41,809 | Institution | 0.11% | 58,491 | |
37,649 | Institution | 0.10% | 52,671 | |
1,708 | Institution | <0.01% | 2,389 |
Holder | # of Shares | Type | % Holding | Value |
---|---|---|---|---|
205,142 | Institution | 0.54% | 286,994 | |
127,757 | Institution | 0.34% | 178,732 | |
84,700 | Institution | 0.22% | 118,495 | |
1,708 | Institution | <0.01% | 2,389 |
Holder | # of Shares | Type | % Holding | Value |
---|---|---|---|---|
37,649 | Institution | 0.10% | 62,874 | |
41,809 | Institution | 0.11% | 58,115 |